RHK RHÖN-KLINIKUM Aktiengesellschaft

15.90USD14.50 EUR · XETRA+0.69%Mkt Cap: 1.06B USDP/E: 22.66

RHÖN-KLINIKUM Aktiengesellschaft, together with its subsidiaries, provides in-patient, semi-patient, and outpatient healthcare services in Germany. The company operates acute hospitals, medical care centers, and rehabili…

Institutional holders1 on file

Key Statistics

Company
Market Cap1.06B USD
Enterprise Value1.11B USD
Revenue (TTM)2.25B USD
Gross Profit211.45M USD
Net Income (TTM)37.81M USD
Revenue/Share33.53 USD
Last Price15.90 USD
Fiscal Year EndDec 2025
MR QuarterSep 2026
Employees19.2K
CountryDE
SectorHealthcare
IndustryMedical Care Facilities
ISINDE0007042301
Valuation
P/E (Trailing)22.66
P/E (Forward)18.35
PEG4.01
EV/EBITDA9.10
EV/Revenue0.49
P/S0.47
P/B0.73
EPS (TTM)0.70 USD
EPS (Forward)0.87 USD
52W Range
13.0568% of range17.22
52W High17.22 USD
52W Low13.05 USD
Profitability
Gross Margin11.31%
Oper. Margin2.73%
EBITDA Margin5.39%
Profit Margin2.02%
ROE2.61%
ROA1.89%
ROIC2.07%
ROCE1.96%
Growth
Revenue Growth5.60%
Earnings Growth-5.80%
Cash Flow & Leverage
Operating CF62.74M USD
CapEx (TTM)108.69M USD
FCF Margin—
FCF Yield—
Net Debt-7.46M USD
Net Debt/EBITDA-0.06
Net Debt/FCF—
Balance Sheet
Debt/Equity0.09
Current Ratio2.69
Quick Ratio1.17
Book Value/Sh21.64 USD
Cash/Share1.92 USD
Dividends
Fwd Div Rate0.22 USD
Trail. Div Rate0.22 USD
Div. Yield1.36%
5Y Avg Yield1.34%
Payout Ratio31.75%
Ex-Div DateMay 28, 2026
Pay Date—
Splits
Last Split2:1
Split DateJul 13, 2007
Analyst Consensus
Rating—
Target (Mean)13.71 USD
Upside (mean)-13.8%
Target Range13.71 USD – 13.71 USD
# Analysts1
Ownership
Shares Out.66.94M
Float3.70M
Insiders95.09%
Institutions0.37%
Technical
SMA 5015.85 (+0.4%)
SMA 20014.70 (+8.2%)
Beta-0.02
S&P 52W Chg12.00%
Avg Vol (30d)497
Avg Vol (10d)842
Technical Indicators
RSI (14)50.9
MACD0.0230
MACD Signal0.0179
MACD Hist.+0.0051
BB Upper16.17 USD
BB Middle15.86 USD
BB Lower15.55 USD
BB Width3.95%
ATR (14)0.3338 USD
Vol Ratio (20d)0.01x

About RHÖN-KLINIKUM (ETR: RHK)

›

RHÖN-KLINIKUM (ETR: RHK) is listed on Xetra (Frankfurt), where its shares trade in EUR. It belongs to the Medical Care Facilities industry, part of the Healthcare sector, and reports about 19,244 employees.

The shares were at 14.50 EUR on 19 November 2026, up 18.9% over 52 weeks. Its 52-week range is 11.90 EUR to 15.70 EUR: the price is 7.6% below the high and 21.8% above the low.

At a market capitalisation of 970.61M EUR, it trades at 22.7 times trailing earnings and 18.4 times forward earnings. The median trailing P/E of its 18 largest Medical Care Facilities peers is 23.7, so RHK is valued in line with them. It pays a dividend yielding 1.36% (it pays out 32% of its earnings), against a median of 0.75% among the dividend payers in that peer group.

RHÖN-KLINIKUM reports return on equity of 2.6%, an operating margin of 2.7% and revenue up 5.6% year over year.

It holds more cash than debt, a net cash position of 6.80M EUR. Its Piotroski F-score is 8 out of 9, a strong reading of its financial health. One analyst covers the stock; their mean price target of 12.50 EUR is 13.8% below the current price. The next earnings report is expected on 25 March 2027.